ICBC Berlin 2026 Drives Dialogue on Med‑Cannabis Market Evolution
ICBC Berlin 2026 delivered three high‑octane days of industry, policy and health dialogue, spotlighting the future of Germany’s medical cannabis market. Stakeholders converged to shape a sustainable, responsible growth path.
The event underscored the critical role of dialogue among industry, politics and health care, especially as regulatory changes now dictate market direction. Regulators, producers and clinicians debated the pace of reform, confirming that policy will drive market momentum.
As a sponsor, the organization met with international partners, regulators and supply‑chain players, exchanging insights on product standards, distribution and compliance. These conversations highlighted collaborative opportunities across borders.
Founder Torsten Greif took the stage in the ‘Surviving and Thriving in Germany’s Canna Industry’ panel, delivering a clear assessment of current market dynamics. He warned that unchecked growth without regulation could jeopardize patient safety and market credibility.
Key agenda items included updating the legal framework, expanding patient access and drawing a precise line between medical use and the recreational market. Speakers agreed that clear legislation will protect consumers and sustain industry expansion.
Continued exchange and evidence‑based education were cited as the only routes to a responsible, long‑term market evolution. Organizers emphasized that ongoing forums will keep stakeholders aligned.
The organizers thanked partners, collaborators and rivals for three productive days in Berlin, reaffirming commitment to a thriving cannabis ecosystem. Future editions will build on this momentum.
